Drug discovery for type 2 diabetes mellitus and metabolic syndrome: ten novel biological targets
In this review we discuss ten promising biological targets of interest for treating type 2 diabetes mellitus, obesity and metabolic syndrome. Namely, we address current experimental and clinical data on several new compounds that affect SGLT2, 11b-HSD1, PTP1B, SCD1, Il-1?. , fructose-1,6-bisphosphat...
Guardado en:
Autores principales: | Ivan Nikolaevich Tyurenkov, Denis Vladimirovich Kurkin, Elena Vladimirovna Volotova, Dmitriy Alexandrovich Bakulin, Elena Michailovna Lomkina |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ea5f94d47de4358a5e6e75c2d440579 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Omega-3 from Flaxseed Oil Protects Obese Mice Against Diabetic Retinopathy Through GPR120 Receptor
por: Marcella Neves Dátilo, et al.
Publicado: (2018) -
GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
por: Wang Jian, et al.
Publicado: (2020) -
Underground Imaging by Sub-Terahertz Radiation
por: Yuan Zheng, et al.
Publicado: (2021) -
A novel GPR119 agonist DA-1241 preserves pancreatic function via the suppression of ER stress and increased PDX1 expression
por: Mi-Kyung Kim, Ph.D, et al.
Publicado: (2021) -
Effect of Ethanol Extract of Whole Plant of Trichosanthes cucumerina var. cucumerina L. on Gonadotropins, Ovarian Follicular Kinetics and Estrous Cycle for Screening of Antifertility Activity in Albino Rats
por: Kage,Devendra N, et al.
Publicado: (2009)